Christopher Sullivan

Chief Accounting Officer

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

AVTX

Current role

Chief Accounting Officer, CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Avalo Therapeutics, Inc. (AVTX)	Chief Financial Officer and principal financial officer	$350,000	—	—	$173,645	$84,000	—	$607,645
2022	Avalo Therapeutics, Inc. (AVTX)	Chief Financial Officer and principal financial officer	$344,135	—	—	$301,614	$72,800	$50,000	$768,549
2021	Avalo Therapeutics, Inc. (AVTX)	Chief Financial Officer and principal financial officer	$300,000	—	—	$241,782	$85,860	—	$627,642

No earnings-call appearances or filed executive changes recorded yet.